Hypera S.A. Return on Equity

Hypera S.A. (HYPMY) currently reports a ROE of 12.02%. That is below the Healthcare sector average of 29.33%. Use the charts on this page to explore Hypera S.A.'s ROE history and peer comparisons.

Hypera S.A.'s ROE of 12.02% is lower than the Healthcare sector average of 29.33%. That is roughly 59.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Hypera S.A.'s current 12.02% should be judged against Healthcare norms (sector average: 29.33%) and against HYPMY's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 12.02%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 29.33%. From there, open related valuation or income-statement pages for Hypera S.A., and consider following HYPMY for alerts when major investors trade the stock.

Hypera S.A. is classified in the Healthcare sector. On ROE, it currently shows 12.02% versus a sector average near 29.33%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HYPMY with unrelated industries.